I'm out!, page-51

I do agree Bucko a CR in a penny bio is of course an action for survival. Every CR for mine inside a cash burn business "breaks the capital structure" because when you raise you raise at a lower level and you of course lower the exit strategy of new holders compared to other pre-existing holders inorder to profit so the vaccum like effect ensues which ultimaltey leads to holders minimising capital loss rather than actually allowing later holders to profit.

Suda isnt a basket case at every level for mine, its unique in its capability of continuing to attract large pharma companies and in parts, do deals with them. Go and dig up the profiles of other bio companies and you'll see we are indeed in a separate basket to many others. If these deals completed were indeed properly managed and perhaps a little tighter legally written you may have a much brighter current position. The strategy isn't completely flawed.

This is where my problem with management and the CEO lies. Not only have existing deals most likely not been properly managed (Teva, Edding, Strides ??) the zero communication surrounding progress must means they simply aren't progressing. The response whenever you question this is that any disclosure will be detrimental to the future success of the relationship and deal which we all should probably conclude is BS.

It's here that my issues are compounded. The CEO lives behind this disclosure barrier which says the market can't be updated because of the adverse potential relationship effects however when you place him and his works in front of a court of law or a regulatory body or another pharma business (all who may be percieved as being in the know and having full disclosure)we have a history of not coming up trumps. This tells me us shareholders may be getting taken for a ride and that the man running the show may well be very incompetent in his dealings which we in most part can't get any exposure too.

I mean why did Artimist not get TGA approval, why did our CEO ensure us we'd all be fine regarding Berlin Pharma, why did the Eddingpharm deal really fall over ?? The answer is none of us have any bloody idea and probably never will, because this "disclosure" issue saves his ass every single time.

In conclusion none of us have any idea just how badly the Steve/Mike team screwed this outfit. What we do know is that whenever we put Carters work In front of the authorities it doesn't appear to stand up. This tells me us shareholders need to do whatever we can to get together and do the obvious to give the business and our holdings a chance of success whilst we still can.